Tags

Type your tag names separated by a space and hit enter

Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors.
Dig Liver Dis. 2012 Nov; 44(11):904-8.DL

Abstract

BACKGROUND

The use of complementary and alternative medicine in inflammatory bowel disease patients is progressively increased.

AIM

To evaluate the use of complementary and alternative medicine in inflammatory bowel disease patients and to know potential risk factors for their use. The subjective response of these therapies and the impact on treatment adherence were also evaluated.

METHODS

Prospective, descriptive and transversal study. Inflammatory bowel disease patients were classified according to demographic and clinical characteristics. A questionnaire about the use of complementary and alternative medicine was collected.

RESULTS

705 patients were included. 126 patients (23%) had used complementary and alternative medicine. The most commonly used was herbal remedies (n=61), homoeopathy (n=36), acupuncture (n=31), kefir (n=31) and aloe vera (n=25). Factors associated with its use were extraintestinal manifestations (OR 1.69, CI 95% 1.11-2.57) and long-term evolution of the disease (OR 2.08, CI 95% 1.44-2.99). Most patients (74%) had the subjective feeling that use of complementary and alternative medicine had not improved their condition, 11 had adverse events related to its use and 11% of patients discontinued their conventional drugs.

CONCLUSIONS

Use of complementary and alternative medicine in inflammatory bowel disease patients is frequent, especially in those with extraintestinal manifestations and long-term evolution. The use of these therapies was not perceived as a benefit for patients.

Authors+Show Affiliations

Gastroenterology Department, POVISA Hospital, Vigo, Spain. afvillaverde@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

22795615

Citation

Fernández, Alberto, et al. "Complementary and Alternative Medicine in Inflammatory Bowel Disease Patients: Frequency and Risk Factors." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 44, no. 11, 2012, pp. 904-8.
Fernández A, Barreiro-de Acosta M, Vallejo N, et al. Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors. Dig Liver Dis. 2012;44(11):904-8.
Fernández, A., Barreiro-de Acosta, M., Vallejo, N., Iglesias, M., Carmona, A., González-Portela, C., Lorenzo, A., & Domínguez-Muñoz, J. E. (2012). Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 44(11), 904-8. https://doi.org/10.1016/j.dld.2012.06.008
Fernández A, et al. Complementary and Alternative Medicine in Inflammatory Bowel Disease Patients: Frequency and Risk Factors. Dig Liver Dis. 2012;44(11):904-8. PubMed PMID: 22795615.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors. AU - Fernández,Alberto, AU - Barreiro-de Acosta,Manuel, AU - Vallejo,Nicolau, AU - Iglesias,Marta, AU - Carmona,Amalia, AU - González-Portela,Carlos, AU - Lorenzo,Aurelio, AU - Domínguez-Muñoz,J Enrique, Y1 - 2012/07/12/ PY - 2012/01/27/received PY - 2012/06/12/revised PY - 2012/06/14/accepted PY - 2012/7/17/entrez PY - 2012/7/17/pubmed PY - 2013/3/19/medline SP - 904 EP - 8 JF - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver JO - Dig Liver Dis VL - 44 IS - 11 N2 - BACKGROUND: The use of complementary and alternative medicine in inflammatory bowel disease patients is progressively increased. AIM: To evaluate the use of complementary and alternative medicine in inflammatory bowel disease patients and to know potential risk factors for their use. The subjective response of these therapies and the impact on treatment adherence were also evaluated. METHODS: Prospective, descriptive and transversal study. Inflammatory bowel disease patients were classified according to demographic and clinical characteristics. A questionnaire about the use of complementary and alternative medicine was collected. RESULTS: 705 patients were included. 126 patients (23%) had used complementary and alternative medicine. The most commonly used was herbal remedies (n=61), homoeopathy (n=36), acupuncture (n=31), kefir (n=31) and aloe vera (n=25). Factors associated with its use were extraintestinal manifestations (OR 1.69, CI 95% 1.11-2.57) and long-term evolution of the disease (OR 2.08, CI 95% 1.44-2.99). Most patients (74%) had the subjective feeling that use of complementary and alternative medicine had not improved their condition, 11 had adverse events related to its use and 11% of patients discontinued their conventional drugs. CONCLUSIONS: Use of complementary and alternative medicine in inflammatory bowel disease patients is frequent, especially in those with extraintestinal manifestations and long-term evolution. The use of these therapies was not perceived as a benefit for patients. SN - 1878-3562 UR - https://www.unboundmedicine.com/medline/citation/22795615/Complementary_and_alternative_medicine_in_inflammatory_bowel_disease_patients:_frequency_and_risk_factors_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1590-8658(12)00213-7 DB - PRIME DP - Unbound Medicine ER -